SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia
- 27 November 2020
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 28 (9) , 1000-1015
Abstract
A high incidence of acute megakaryoblastic leukemia (AMKL) in Down syndrome patients implies that chromosome 21 genes have a pivotal role in AMKL development, but the functional contribution of individual genes remains elusive. Here, we report that SON, a chromosome 21-encoded DNA- and RNA-binding protein, inhibits megakaryocytic differentiation by suppressing RUNX1 and the megakaryocytic gene expression program. As megakaryocytic progenitors differentiate, SON expression is drastically reduced, with mature megakaryocytes having the lowest levels. In contrast, AMKL cells express an aberrantly high level of SON, and knockdown of SON induced the onset of megakaryocytic differentiation in AMKL cell lines. Genome-wide transcriptome analyses revealed that SON knockdown turns on the expression of pro-megakaryocytic genes while reducing erythroid gene expression. Mechanistically, SON represses RUNX1 expression by directly binding to the proximal promoter and two enhancer regions, the known +23 kb enhancer and the novel +139 kb enhancer, at the RUNX1 locus to suppress H3K4 methylation. In addition, SON represses the expression of the AP-1 complex subunits JUN, JUNB, and FOSB which are required for late megakaryocytic gene expression. Our findings define SON as a negative regulator of RUNX1 and megakaryocytic differentiation, implicating SON overexpression in impaired differentiation during AMKL development.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R01CA190688, R01CA236911, R01HL136432)
- U.S. Department of Health & Human Services | National Institutes of Health
- UAB | Comprehensive Cancer Center, University of Alabama at Birmingham
- UAB | School of Medicine, University of Alabama at Birmingham
- UAB, Department of Pathology
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 65 references indexed in Scilit:
- Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21Proceedings of the National Academy of Sciences, 2012
- Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cellsProceedings of the National Academy of Sciences, 2012
- SON Controls Cell-Cycle Progression by Coordinated Regulation of RNA SplicingMolecular Cell, 2011
- Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndromeOncogene, 2010
- miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemiaGenes & Development, 2010
- The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomiesProceedings of the National Academy of Sciences, 2009
- DOCK5 and DOCK1 Regulate Caco-2 Intestinal Epithelial Cell Spreading and Migration on Collagen IVJournal of Biological Chemistry, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Acute megakaryoblastic leukemia: experience of GIMEMA trialsLeukemia, 2002